Rachelle Buchbinder

Last updated

Rachelle Buchbinder

AO FAHMS
Rachelle Buchbinder - First do no harm, from 'Women', Sam Burke and Rebecca Umlauf, 2019.jpg
Rachelle Buchbinder, portrait from the exhibition 'Women', 2019
Born1958
NationalityAustralian
EducationMBBS (Hons), MSc, PhD, FRACP
Alma materMonash University, University of Toronto
Occupation(s)Rheumatologist and clinical epidemiologist
Employer(s)Monash University, School of Public Health and Preventive Medicine, and Monash Department of Clinical Epidemiology – Cabrini Institute
Known forResearch into arthritis and musculoskeletal conditions, improving communication with patients and health literacy

Rachelle Buchbinder AO FAHMS (born 1958) is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.

Contents

Education

Buchbinder holds a Bachelor of Medicine, Bachelor of Surgery, (MBBS) (Hons) from Monash University in Melbourne, Australia. [1]

She earned a Master of Science (MSc) in Clinical Epidemiology from Toronto University, Canada in 1993. Her thesis topic was "The classification of soft tissue disorders of the neck and upper limb for epidemiological research." [2]

The topic for Buchbinder's doctoral dissertation was "Short and long-term effects of a public health media campaign designed to reduce disability associated with back pain. [3] " Her PhD was awarded in 2006 by Monash University, Melbourne.

Career

Buchbinder was made founding Director of the Monash Department of Clinical Epidemiology in 2001. [4] She became Professor in the Monash University Department of Epidemiology and Preventive Medicine in 2007. [4]

Buchbinder is currently (2020) an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. [5] She is also Coordinating Editor of the Cochrane Musculoskeletal Group [6] which "produces reliable, up-to-date reviews of interventions for the prevention, treatment or rehabilitation of musculoskeletal disorders in the form of systematic reviews." [7]

Buchbinder is a founding member and, current Steering Group Chair of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network. [8]

In 2015 Buchbinder was made a Fellow of the Australian Academy of Health and Medical Sciences. [9]

She was President of the Australian Rheumatology Association from 2016 to 2018 [10] and is currently (2020) Chair, Australian Rheumatology Association Database (ARAD) Management Committee [4] and Registry Custodian of the Australian Rheumatology Association Database. [11]

Buchbinder chaired the steering group for The Lancet Low Back Pain Series [12] [13] [14] which published 3 papers in March 2018. [15] The series looks to reverse the trend of ineffective and dangerous treatments for lower back pain which has both personal and global impacts. [15]

She has a broad range of multidisciplinary research projects relating to arthritis and musculoskeletal conditions as well as improving communication with patients and health literacy [5] which are funded by National Health and Medical Research Council (NHMRC) schemes and research grants. These include reducing over testing, over-diagnosis and waste in health care, identifying more efficient service delivery models, implementing the Australian Clinical Care Standard for osteoarthritis of the knee and developing a decision aid for knee arthroscopy, developing a set of outcome measures for trials of shoulder disorders, developing a Back Pain Burden Questionnaire and the Back Pain Misconceptions Questionnaire, investigating support for people with sub-optimal health literacy and studying the long term outcome of inflammatory arthritis in Australia. [4]

Buchbinder is frequently consulted as a spokesperson for evidence-based care and waste of resources in medicine particularly in her specialist fields. [16] [17] [18] [19] By 2019 she had published over 540 papers, been cited 48,078 times, [20] and inspired many clinician-scientists. [9]

The high influence of her work is evidenced by her recognition by Clarivate Analytics as a Highly Cited Researcher (in top 1% by citations across more than one field) in both 2018 and 2019. [21] [22]

Awards

Buchbinder won the Volvo Award in Clinical Studies 2001 [23] and the Triennial Parr Prize in Rheumatology, 2004. [24]

In February 2007 Buchbinder's doctoral thesis won the Mollie Holman Doctoral Medal for Excellence, Faculty of Medicine, Nursing and Health Sciences [25] [3]

She received a commendation in Premier's Award for Medical Research (Victoria) in 2007 for her evaluation of impact of a mass-media campaign ‘Back Pain: Don't take it lying down’. The campaign aimed to educate Victorians about back pain and provide up to date advice on its management. Globally it was the first implementation of a public health approach for back-related disability. [25]

In 2010 she was honoured as the Metro Ogryzlo Professor for the annual Ogryzlo Day in Toronto, Canada. [26]

Buchbinder held a NHMRC Practitioner Fellowship from 2005 to 2014 [27] and currently holds an NHMRC Senior Principal Research Fellowship 2015 to 2020.

In 2016 Buchbinder gave the Opening Plenary at the IV International Low Back and Neck Pain Forum. [28]

In both 2010 and 2011 she and her colleagues won the Helen Moran Award from Arthritis Victoria [27]

In 2018 she was awarded a Rockefeller Foundation Academic Writing Fellowship at the Bellagio Centre in Italy. [29]

In January 2020 Buchbinder was made an Officer (AO) in the General Division of the Order of Australia for "distinguished service to medical education in the fields of epidemiology and rheumatology, and to professional associations." [30] [31]

In October 2022 the Council of the Royal Society of Victoria announced Buchbinder for the 2022 Medal for Excellence in Scientific Research (Category II – the Biomedical and Health Sciences). The Research Medal recognises peak research career achievements and outstanding leadership in research by scientists working in the State of Victoria. [32]


Related Research Articles

<span class="mw-page-title-main">Arthritis</span> Type of joint disorder

Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness, warmth, swelling, and decreased range of motion of the affected joints. In some types of arthritis, other organs are also affected. Onset can be gradual or sudden.

<span class="mw-page-title-main">Rheumatoid arthritis</span> Type of autoimmune arthritis

Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints. Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. The disease may also affect other parts of the body, including skin, eyes, lungs, heart, nerves, and blood. This may result in a low red blood cell count, inflammation around the lungs, and inflammation around the heart. Fever and low energy may also be present. Often, symptoms come on gradually over weeks to months.

<span class="mw-page-title-main">Gout</span> Form of arthritis causing swollen joints

Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot and swollen joint, caused by the deposition of needle-like crystals of uric acid known as monosodium urate crystals. Pain typically comes on rapidly, reaching maximal intensity in less than 12 hours. The joint at the base of the big toe is affected (Podagra) in about half of cases. It may also result in tophi, kidney stones, or kidney damage.

Rheumatology is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones, muscles, joints, and internal organs. Rheumatology covers more than 100 different complex diseases, collectively known as rheumatic diseases, which includes many forms of arthritis as well as lupus and Sjögren's syndrome. Doctors who have undergone formal training in rheumatology are called rheumatologists.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

<span class="mw-page-title-main">Juvenile idiopathic arthritis</span> Childhood rheumatic disease

Juvenile idiopathic arthritis (JIA), formerly known as juvenile rheumatoid arthritis (JRA), is the most common chronic rheumatic disease of childhood, affecting approximately 3.8 to 400 out of 100,000 children. Juvenile, in this context, refers to disease onset before 16 years of age, while idiopathic refers to a condition with no defined cause, and arthritis is inflammation within the joint.

Prolotherapy, also called proliferation therapy, is an injection-based treatment used in chronic musculoskeletal conditions. It has been characterised as an alternative medicine practice.

The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.

<span class="mw-page-title-main">Enteropathic arthropathy</span> Medical condition

Enteropathic arthropathy commonly referred to as enteropathic arthritis, is a type of arthritis linked to Crohn's disease, ulcerative colitis, and chronic inflammatory bowel diseases.

Matthew H. Liang is a physician specializing in general internal medicine and rheumatology, Professor of Medicine at Harvard Medical School, Professor of Health Policy and Management at Harvard School of Public Health, and the Director Emeritus of Special Projects of the Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center which he founded. He is a founding faculty of the Division of General Internal Medicine and Primary Care at the Brigham and Women's Hospital and a founding faculty of the Clinical Effectiveness Program at the Harvard School of Public Health and is a Study Director in the Veterans Administration Cooperative Studies Program.

Amanda Jane Fosang is a biomedical researcher who has pioneered arthritis research in Australia.

Sarah Elizabeth Lamb is the Pro-Vice-Chancellor and Executive Dean of the Faculty of Health and Life Sciences at the University of Exeter, and the Mireille Gillings Professor for Health Innovation. She is also an Honorary Departmental Professor at the Nuffield Department of Medicine, University of Oxford and was the Foundation Director of the Oxford Clinical Trials Research Unit.

Michelle Leech is the Deputy Dean of Medicine at Monash University and an academic clinician-scientist. Leech oversees the delivery of the Monash medical program and maintains an active research profile and clinical practice as a rheumatologist.

Sir Martin Jonathan Landray is a British physician, epidemiologist and data scientist who serves as a Professor of Medicine & Epidemiology at the University of Oxford. Landray designs, conducts and analyses large-scale randomised control trials; including practice-changing international trials that have recruited over 100,000 individuals. Landray previously led the health informatics team that enabled the collection and management of data for the UK Biobank on over half a million people.

Nancy E. Lane is an American rheumatologist. She is an Endowed Professor of Medicine, Rheumatology, and Aging Research at the University of California, Davis and director of the UC Davis Musculoskeletal Diseases of Aging Research Group. She has also sat on the editorial boards of Nature Reviews Rheumatology, Rheumatology,Seminars in Arthritis and Rheumatism,Arthritis & Rheumatology, and The Journal of Rheumatology.

<span class="mw-page-title-main">Emily Banks</span> Epidemiologist and public health researcher

Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.

<span class="mw-page-title-main">Lindsey A. Criswell</span> American physician

Lindsey A. Criswell is an American rheumatologist and physician-scientist. She is director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Criswell was vice chancellor of research at University of California, San Francisco where she held the Jean S. Engleman Distinguished Professorship in Rheumatology.

<span class="mw-page-title-main">Robert H. Carter</span>

Robert H. Carter is an American rheumatologist and physician-scientist serving as the deputy director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) since 2008. He was the acting director of NIAMS from December 2018 until February 2021.

<span class="mw-page-title-main">Mariana J. Kaplan</span> Physician Scientist/ Rheumatologist

Mariana J. Kaplan is a rheumatologist and physician-scientist. She researches mechanisms of immune dysregulation, organ damage, and premature vascular disease in systemic autoimmunity. Kaplan is chief of the systemic autoimmunity branch at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Paul Emery is a British rheumatologist, researcher, and academic. Emery has been the Versus Arthritis Professor of Rheumatology at the University of Leeds since 1995, Head of its Rheumatology Department from 1995 to 2008. He is Head of the Academic Unit of Musculoskeletal Disease and Lead Clinician of Rheumatology at the Leeds Teaching Hospital NHS Trust, and was the Director of the NIHR Leeds Biomedical Research Centre from 2009 to 2022. He is known for introducing early intervention in inflammatory arthritis. Emery played a critical role in bringing sensitive imaging (MRI) into rheumatology practice. In 2012, Emery was awarded the Carol Nachman Prize for Rheumatology, and as of 2023, he has published over 1250 peer-reviewed articles.

References

  1. ↑ "Rachelle Buchbinder". Monash University, Profiles. Retrieved 29 March 2020.
  2. ↑ Buchbinder, Rachelle (1993). The classification of soft tissue disorders of the neck and upper limb for epidemiological research. Canadian theses = Thèses canadiennes. Ottawa : National Library of Canada = Bibliothèque nationale du Canada, 1993: Thesis (M.Sc.) University of Toronto, Canada. ISBN   0315833963.{{cite book}}: CS1 maint: location (link)
  3. 1 2 Buchbinder, Rachelle (2006). Short and long-term effects of a public health media campaign designed to reduce disability associated with back pain. Thesis (Ph.D.) Monash University. OCLC   225407847.
  4. 1 2 3 4 "Monash University, Personal profile: Rachelle Buchbinder". Monash University. Retrieved 29 February 2020.
  5. 1 2 "Professor Rachelle Buchbinder – Health Sustainability Systems". www.healthsystemsustainability.com.au. Retrieved 29 February 2020.
  6. ↑ "CMSG Editors". Cochrane Musculoskeletal. Retrieved 29 February 2020.
  7. ↑ "Welcome". musculoskeletal.cochrane.org. Retrieved 29 February 2020.
  8. ↑ "Executive Committee". ANZMUSC. Retrieved 29 February 2020.
  9. 1 2 "Fellowship". AAHMS - Australian Academy of Health and Medical Sciences. Retrieved 1 April 2020.
  10. ↑ "List of ARA Presidents From Foundation to Present" (PDF). Australian Rheumatology Association. Retrieved 29 February 2020.
  11. ↑ "Australian Rheumatology Association Database (ARAD)". Public Health and Preventive Medicine. Retrieved 29 February 2020.
  12. ↑ Hartvigsen, Jan; Hancock, Mark J.; Kongsted, Alice; Louw, Quinette; Ferreira, Manuela L.; Genevay, Stéphane; Hoy, Damian; Karppinen, Jaro; Pransky, Glenn; Sieper, Joachim; Smeets, Rob J. (9 June 2018). "What low back pain is and why we need to pay attention". The Lancet. The Lancet Low Back Pain Series. 391 (10137): 2356–2367. doi:10.1016/S0140-6736(18)30480-X. hdl: 1871.1/79cd95b7-4b74-4c5a-bf1f-adf61bcc71f5 . ISSN   0140-6736. PMID   29573870. S2CID   4354991.
  13. ↑ Foster, Nadine E.; Anema, Johannes R.; Cherkin, Dan; Chou, Roger; Cohen, Steven P.; Gross, Douglas P.; Ferreira, Paulo H.; Fritz, Julie M.; Koes, Bart W.; Peul, Wilco; Turner, Judith A. (9 June 2018). "Prevention and treatment of low back pain: evidence, challenges, and promising directions". The Lancet. The Lancet Low Back Pain Series. 391 (10137): 2368–2383. doi:10.1016/S0140-6736(18)30489-6. hdl: 1871.1/29f62103-4a44-46d4-aceb-122783bab370 . ISSN   0140-6736. PMID   29573872. S2CID   205989057.
  14. ↑ Buchbinder, Rachelle; Tulder, Maurits van; Öberg, Birgitta; Costa, Lucíola Menezes; Woolf, Anthony; Schoene, Mark; Croft, Peter; Buchbinder, Rachelle; Hartvigsen, Jan; Cherkin, Dan; Foster, Nadine E. (9 June 2018). "Low back pain: a call for action" (PDF). The Lancet. The Lancet Low Back Pain Series. 391 (10137): 2384–2388. doi:10.1016/S0140-6736(18)30488-4. ISSN   0140-6736. PMID   29573871. S2CID   4348151.
  15. 1 2 "About us - Recent achievements, Professor Rachelle Buchbinder". Public Health and Preventive Medicine, Monash University. Retrieved 26 March 2020.
  16. ↑ "Audio Segment Treatment for osteoporotic vertebral fractures". ABC Radio National. 6 August 2009. Retrieved 30 March 2020.
  17. ↑ 4Corners: Wasted, Australian Broadcasting Corporation, 28 September 2015, retrieved 30 March 2020
  18. ↑ Buchbinder, Rachelle (15 January 2020). "In defence of thongs ... and science". The Sydney Morning Herald. Retrieved 30 March 2020.
  19. ↑ z3525182 (14 September 2018). "Needless procedures: Knee arthroscopy one of the least effective surgeries". UNSW Newsroom. Retrieved 30 March 2020.{{cite web}}: CS1 maint: numeric names: authors list (link)
  20. ↑ "Rachelle Buchbinder's Publons profile". publons.com. Retrieved 10 April 2020.
  21. ↑ "Global Highly Cited Researchers 2018 List Reveals Influential Scientific Researchers and their Institutions". Clarivate. 27 November 2018. Retrieved 10 April 2020.
  22. ↑ "Global Highly Cited Researchers 2019 list reveals top talent in the sciences and social sciences". Clarivate. 19 November 2019. Retrieved 10 April 2020.
  23. ↑ Buchbinder, R; Jolley, D.; Wyatt, M. (1 December 2001). "2001 Volvo Award Winner in Clinical Studies: Effects of a media campaign on back pain beliefs and its potential influence on management of low back pain in general practice". Spine (Phila Pa 1976). 26 (23): 2535–42. doi:10.1097/00007632-200112010-00005. PMID   11725233. S2CID   31066336.
  24. ↑ "Officer (AO) in the General Division of The Order Of Australia; Media Notes" (PDF). The Governor General of the Commonwealth of Australia, Australia Day 2002 Honours List. 2020. p. 11. Retrieved 30 March 2020.
  25. 1 2 Department of Epidemiology and Preventive Medicine (DEPM) Annual Report, 2007; Awards, prizes and fellowships in 2007 (PDF). Melbourne, Australia: Monash University; Medicine, Nursing and Health Sciences. 2007. p. 11.
  26. ↑ "Monash University, School of Public Health and Preventive Medicine Annual Report 2010" (PDF). Monash University. 2010. p. 44. Retrieved 10 April 2020.
  27. 1 2 Monash University, School of Public Health and Preventive Medicine Annual Report 2011 (PDF). Melbourne, Australia: Monash University. 2011. p. 58.
  28. ↑ Monash University, School of Public Health and Preventive Medicine Annual Report 2016. Monash University, Melbourne. 2016. p. 28.
  29. ↑ "Cabrini Institute Annual Report 2017-18". Issuu. p. 23. Retrieved 10 April 2020.
  30. ↑ "Rheumatologist recognised in the 2020 Australia Day honours". thelimbic. Retrieved 29 March 2020.
  31. ↑ "2020 Australia Day Awards". J-Wire. 28 January 2020. Retrieved 29 March 2020.
  32. ↑ "RSV RESEARCH MEDAL AWARDED TO PROFESSOR RACHELLE BUCHBINDER AO". RSV. Retrieved 21 October 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.